HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bromoacetate (bromoacetic acid)

Also Known As:

bromoacetic acid; monobromoacetate

Networked: 8 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - bromoacetate: 8
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Acetates: 4994
      - bromoacetate: 8

Experts

1.	Alderden, Rebecca A: 1 article (07/2006)
2.	Beale, Philip J: 1 article (07/2006)
3.	Cai, Zhonghou: 1 article (07/2006)
4.	Hall, Matthew D: 1 article (07/2006)
5.	Hambley, Trevor W: 1 article (07/2006)
6.	Lai, Barry: 1 article (07/2006)
7.	Stampfl, Anton P J: 1 article (07/2006)
8.	Zhang, Mei: 1 article (07/2006)

Related Diseases

1.	Osteosarcoma (Osteogenic Sarcoma) 12/01/1996 - "Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3." 12/01/1997 - "Recently our laboratory has developed 1 alpha,25-dihydroxyvitamin D3-3 beta-bromoacetate (1,25(OH)2 D3-3-BE) as an affinity labeling reagent for covalently modifying the hormone binding domain of native VDRs from calf thymus and rat osteosarcoma cells and baculovirus-expressed recombinant human VDR (hVDR). " 01/26/1996 - "In order to study this key step in the cascade, we synthesized 1 alpha,25-dihydroxy[26(27)-3H]vitamin D3-3-deoxy-3 beta-bromoacetate (1,25(OH)2[3H]D3-BE) and 1 alpha,25-dihydroxyvitaminD3-3 beta-[1-14C]bromoacetate(1,25(OH)2D3-[14C]BE) binding-site directed analogs of 1,25(OH)2D3, and affinity-labeled baculovirus-expressed recombinant human VDR (with 1,25(OH)2[3H]D3-BE), and naturally occurring VDRs in cytosols from calf thymus homogenate and rat osteosarcoma (ROS 17/2.8) cells (with 1,25(OH)2D3-[14C]BE). "
2.	Neuroblastoma 03/01/1978 - "Since the neuroblastoma-inoculated A/J mice are considered to be comparable to human neuroblastoma, the cytolytic action of bromoacetylcholine and bromoacetate on murine neuroblastoma warrants further studies on patients. " 03/01/1978 - "Bromoacetylcholine (30 mg/kg intratumor one to three times per day) and bromoacetate (12 mg/kg intratumor two times per day) inhibited neuroblastoma in A/J mice efficiently and prolonged the lifespan of these animals at least 200%. " 03/01/1978 - "Treatment of neuroblastoma in mice with bromoacetylcholine and bromoacetate."
3.	Inflammation (Inflammations) 11/20/2022 - "Our study found that bromoacetic acid (BAA, a typical kind of environmental toxin) increased triglycerides and total cholesterol levels as well as induced obvious hepatic steatosis and inflammation. "
4.	Neoplasms (Cancer) 07/01/2006 - "SRIXE maps were collected of thin sections of human ovarian (A2780) cancer cells treated with bromine containing platinum complexes, cis-[PtCl(2)(3-Brpyr)(NH(3))] (3-Brpyr=3-bromopyridine) and cis,trans,cis-[PtCl(2)(OAcBr)(2)(NH(3))(2)] (OAcBr=bromoacetate), or a platinum complex with an intercalator attached cis-[PtCl(2)(2-[(3-aminopropyl)amino]-9,10-anthracenedione)(NH(3))]. "
5.	Myocardial Infarction 07/01/1993 - "Murine antimyosin Fab fragment was conjugated with 111In-labeled N-terminal-modified DTPA-polylysine using three bifunctional reagents: N-hydroxysuccinimide esters of 3-(2-pyridyldithio)propionic acid (SPDP conjugate), 4-(maleimidomethyl)cyclohexanecarboxylic acid (SMCC conjugate) and bromoacetic acid (BrAc conjugate) for potential localization of experimental myocardial infarction. "

Related Drugs and Biologics

1.	Vitamins
2.	Triglycerides (Triacylglycerol)
3.	Cholesterol
4.	Calcitriol (Calcijex)
5.	Acetylcholine (Acetylcholine Chloride)
6.	hydroxide ion
7.	Polylysine
8.	Platinum
9.	Intercalating Agents
10.	Indicators and Reagents (Reagents)